The firm says it could offer an alternative to existing treatments while sidestepping addiction concerns that have plagued ...

In terms of valuation, Mira Pharmaceuticals Inc’s market capitalization stands at $15.52 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

北京时间2024年10月22日00时51分，苏轩堂（SXTC.us）股票出现波动，股价急速 拉升 6.30%。截至发稿，该股报0.670美元/股，成交量19.618万股， 换手率 5.64%，振幅10.74%。

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

"We are fully committed to bringing this breakthrough drug to patients as quickly as possible while backing everything we do ...

It was unclear what role Bubeck would assume at the Microsoft-backed AI startup. "Sebastian has decided to leave Microsoft to ...

Welcome to Edition 7.15 of the Rocket Report! It's a big week for big rockets, with SpaceX potentially launching its next ...

Legalcategory Western Digital owes $315.7 million for infringing data security patent, US jury says 9:10 PM UTC · Updated ago ...

Dr. Prendergast has led the approval of three new drug applications and played a pivotal role in the successful sale of Vylessi® to Cosette Pharmaceuticals for USD $12M, marking a significant ...

Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic pain MIAMI, FL / ACCESSWIRE / September 27, 2024 / MIRA Pharmaceuticals ...